Zoetis Takes Action Amid Takeover Threat
November 19, 2014
Facing a possible hostile takeover, veterinary drug maker Zoetis Inc. has authorized a $500 million stock buyback program and the sale of preferred shares to stockholders at a discount. Neither action is guaranteed to happen. The first is at the discretion of the Zoetis board of directors, and the second—a so-called “poison pill”—would kick in… Continue reading...